Several biomarker tests have been available for over a decade, with extensive research backing their effectiveness. Yet, many ...

According to Research by SNS Insider, Global Prostate Cancer Diagnostics Market Growth is Fueled by Growing Demand for Advanced Biomarker Testing, AI Diagnostics, and Outpatient Screening Services ...

Medically reviewed by Jamin Brahmbhatt, MD The treatment of metastatic castration-resistant prostate cancer (mCRPC) involves ...

MPS2 is a urine-based test that measures 18 prostate cancer-related biomarkers to assess a man's risk of harboring clinically significant prostate cancer. The analytical validation showed that all ...

Guidelines created by a multi-disciplinary panel of specialists focus on implementation of novel treatments and technologies for which level 1 evidence is lacking.

Early-onset CRC (EO-CRC) was associated with Flavonifractor plautii and increased bile acid, tryptophan, and choline ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which ...

Study finds MPS2 scores are highly reproducible across DRE and non-DRE urine samples alike. "This study reinforces the value of MPS2 as a non-invasive diagnostic tool that delivers consistent and ...